Back to GLPGF
MARSHALL WACE, LLP GLPGF Position History
Lakefront Biotherapeutics NV • Healthcare
Quarters held
10
Latest value
$2.3M
Q3 2026
Peak value
$2.3M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $496K |
| Q2 2023 | $1.8M |
| Q2 2024 | $315K |
| Q3 2025 | $1.3M |
| Q4 2025 | $199K |
| Q4 2025 | $167K |
| Q2 2026 | $17K |
| Q2 2026 | $955K |
| Q3 2026 | $46K |
| Q3 2026 | $2.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.3M | 76.9K | — | — |
| Q3 2026 | $46K | 1.5K | — | — |
| Q2 2026 | $955K | 31.8K | — | — |
| Q2 2026 | $17K | 554 | — | — |
| Q4 2025 | $167K | 5.1K | — | — |
| Q4 2025 | $199K | 6.1K | — | — |
| Q3 2025 | $1.3M | 38.5K | — | — |
| Q2 2024 | $315K | 12.7K | — | — |
| Q2 2023 | $1.8M | 43.6K | — | — |
| Q1 2023 | $496K | 12.8K | — | — |
Other funds holding GLPGF
$578.7M
$550.6M
$501.3M
$501.2M
$500.2M
$174.9M
$150M
$147.8M